SCHEMBL4292198

SCHEMBL4292198

COc1ccc(Cc2ccc(CO)nc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 3/20 0.50
POLB P06746 1/20 0.45
ALDH1A1 P00352 3/20 0.45
LMNA P02545 2/20 0.45
SAE1 Q9UBE0 1/20 0.45
UBA2 Q9UBT2 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
P2RX7 Q99572 1/20 0.42
CYP2D6 P10635 1/20 0.41
ATM Q13315 1/20 0.41
IDO1 P14902 1/20 0.40
CYP11B1 P15538 1/20 0.40
CYP11B2 P19099 1/20 0.40
MIF P14174 1/20 0.40
HPGD P15428 1/20 0.40
PDGFRB P09619 1/20 0.39
PDGFRA P16234 1/20 0.39
CASP3 P42574 1/20 0.39
SENP8 Q96LD8 1/20 0.39
SENP7 Q9BQF6 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL731990 0.82 P2RX7 (0.45) ALDH1A1P2RX7CYP11B1CYP11B2HPGD
SCHEMBL29723725 0.82 P2RX7 (0.45) ALDH1A1P2RX7CYP11B1CYP11B2HPGD
SCHEMBL29723727 0.82 P2RX7 (0.45) ALDH1A1P2RX7CYP11B1CYP11B2HPGD
SCHEMBL11631724 0.79 SAE1 (0.46) LTA4HPOLBALDH1A1LMNASAE1
SCHEMBL5109315 0.79 CALM1 (0.46) LTA4HALDH1A1LMNACYP11B1CYP11B2
SCHEMBL8993364 0.78 LTA4H (0.65) LTA4HALDH1A1LMNASAE1UBA2
SCHEMBL10242538 0.77 LTA4H (0.55) LTA4HPOLBALDH1A1LMNASAE1
SCHEMBL28585249 0.77 APP (0.54) IDO1
SCHEMBL18359648 0.77 TP53 (0.47) LTA4HPOLBALDH1A1LMNASAE1
SCHEMBL18666584 0.77 MAOB (0.51) LTA4HPOLBALDH1A1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101472937-A Benzylphenylglucopyranoside Derivatives DAIICHI SANKYO CO LTD (JP) 2009-07-01 CN disclosed
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-05-28 US disclosed
EP-2048150-A1 BENZYL PHENYL GLUCOPYRANOSIDE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2009-04-15 EP disclosed
US-4109000-A HYPOTENSIVES NIPPON SHINYAKU CO., LTD. (JP) 1978-08-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE SLC5A1, SLC5A2, SLC2A1 LTA4H 4204/4885POLB 4872/4885ALDH1A1 896/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.